Kalypsys has promoted John McKearn, former chief scientific officer, to president and CSO, the company announced last week. McKearn joined Kalypsys in July 2003 from Pharmacia, where he was senior vice president of research.

Kalypsys also added two new members to its board of directors, Kenneth Langone and Al Heller.

Langone is the co-founder and current board member of Home Depot, and is currently the president, CEO, and chairman of Invemed Associates, an investor in Kalypsys’ series B financing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.